Top Markets
#1 pippin pippin +16.86%
#2 Aria.AI Aria.AI +14.74%
#3 River Pts River Pts +14.68%
#4 Janction Janction +13.50%
#5 Strategic Oil Supply Strategic Oil Supply +12.21%
#6 TRIA TRIA +12.05%
#7 DeXe DeXe +11.31%
#8 Osaka Protocol Osaka Protocol +10.09%
#9 Lava Network Lava Network +8.51%
#10 Orochi Network Orochi Network +8.44%
Coin of the day
pippin pippin
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Hisse Senetlerindeki Sıralama #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Hisse Fiyatı
$37.45
Piyasa Değeri
$166.43B
Değişim (1 gün)
-2.55%
Değişim (1 yıl)
-53.09%
Ülke
DK
Ticaret Novo Nordisk A/S (NVO)

Kategori

Healthcare
Novo Nordisk A/S (NVO) için kazanç
2026 itibarıyla kazanç TTM: 0
Novo Nordisk A/S şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Novo Nordisk A/S için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.45B -
NL